Variant report
Variant | nsv969251 |
---|---|
Chromosome Location | chr5:152619724-152635191 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540507598 | chr5:152626211-152626212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565402542 | chr5:152626286-152626287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532557679 | chr5:152626296-152626297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192556204 | chr5:152626328-152626329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34987547 | chr5:152626400-152626401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563009330 | chr5:152626412-152626413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530208369 | chr5:152626464-152626465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184288213 | chr5:152626488-152626489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566656704 | chr5:152626505-152626506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527450328 | chr5:152626528-152626529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144171511 | chr5:152626536-152626537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs570608563 | chr5:152626541-152626542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189194274 | chr5:152626551-152626552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113329288 | chr5:152626572-152626573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568196364 | chr5:152626576-152626577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535159356 | chr5:152626578-152626579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554774842 | chr5:152626599-152626600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181365266 | chr5:152626615-152626616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540396809 | chr5:152626640-152626641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186518487 | chr5:152626653-152626654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559203194 | chr5:152626677-152626678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2926290 | chr5:152626704-152626705 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs544633951 | chr5:152626737-152626738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189010330 | chr5:152626770-152626771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181690239 | chr5:152626773-152626774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10477051 | chr5:152626786-152626787 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs560543626 | chr5:152626832-152626833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527487123 | chr5:152626858-152626859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552046371 | chr5:152626882-152626883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570768945 | chr5:152626904-152626905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554092479 | chr5:152626917-152626918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs139468447 | chr5:152626952-152626953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572655726 | chr5:152626980-152626981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144208485 | chr5:152626994-152626995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535047415 | chr5:152627024-152627025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186182014 | chr5:152627058-152627059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10071927 | chr5:152627059-152627060 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs200916254 | chr5:152627061-152627062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs377252181 | chr5:152627076-152627077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534133962 | chr5:152627084-152627085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs57338666 | chr5:152627088-152627089 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs200188605 | chr5:152627091-152627092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190901900 | chr5:152627160-152627161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538133514 | chr5:152627166-152627167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556783067 | chr5:152627186-152627187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112908864 | chr5:152627189-152627190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Deafness | 19353646 | CNVD |
Developmental delay | 19353646 | CNVD |
dysmorphism | 19353646 | CNVD |
feeding difficulties | 19353646 | CNVD |
strabismus | 19353646 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:152626200-152627000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr5:152626200-152627000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr5:152626800-152627000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr5:152626800-152627200 | Enhancers | HUES48 Cell Line | embryonic stem cell |